Daphnetin was reported as a potent intestinal anti-inflammatory coumarin derivative in the TNBS model of intestinal inflammation in rats, reducing gut damage lesions, MPO, and alkaline phosphatase activities, and counteracting GSH depletion when orally administered at doses of 2.5, 5, and 10 mg/Kg [84]. Here, MPO is linked to gastroenteritis.